Distributors / Reps

Find out how IMDA can help you achieve excellence in specialty sales and marketing.

Service Members

Find out how you can sell your service to IMDA members

  • Access to all members
  • Build Loyalty by offerring your brand at group discounts

Meet an IMDA Member


Salt Lake City, Utah

Contact: Bruce Brierley, President and CEO

Primary specialties: Manufacturer of gas sensing, analysis and delivery products


Biggest challenge in next 12 months:

Maxtec is preparing for the next level of growth after securing a new facility with surrounding land for expansion (2013-15). We are well on our way in recruiting new team members that come with a next level of experience to help us become a $50 million to $100 million entity.

During the next 12 months, we will be addressing internal systems and processes. We will be addressing new software systems, LEAN, Six Sigma, Kaizen processes that can help us improve efficiencies and lower cost in how we manufacture and operate. In order to pay for the new people, we need to reduce waste and improve our throughput. We also need to increase sales and get our new products successfully introduced

Biggest opportunity in next 12 months:

Maxtec is fortunate to be well positioned with its gas sensing, flow delivery and equipment stand bundles to gain from the hottest new oxygen modality Heated High Flow Nasal Cannula Therapy. High flow is rapidly growing in the OR, RT, ED, ICU and even Home Care. It allows a patient to comfortably get 40-50 LPM of flow through a comfortable nasal cannula, which patients are prone to be more compliant to wear.  

 We are very excited about the new products that have just been introduced -- our 02 monitor and Maxblend. It seems like it took forever to get them to market, but the end result is very impressive and well received.

 Maxtec has some exciting large capital products for the NICU and L&D that command the attention of the key opinion leaders. They are truly hot-topic products for brain cooling and delayed cord clamping.  

IMDA eNews   10/03/16                                                       Subscribe


    UPS has begun testing the use of drones to make commercial deliveries of packages to remote or difficult-to-access locations, working together with drone-maker CyPhy Works. The companies staged a mock delivery of urgently needed medicine from Beverly, Mass., to Children’s Island, which is about three miles off the Atlantic coast. In the mock scenario, the drone successfully carried an asthma inhaler to a child at a camp on the island, which is not reachable by automobile. The drone flight advances an investment made by The UPS Strategic Enterprise Fund in CyPhy to gather information about drone uses and capabilities.


    The Centers for Medicare & Medicaid Services (CMS) and its contractors have expressed concerns about the recent substantial increase in Medicare billing for noninvasive pressure support ventilators, according to the Office of Inspector General. In recent years, ventilator technology has evolved so that it is possible for a single device to treat numerous conditions by operating in several different modes - i.e., basic continuous positive airway pressure (CPAP) mode, respiratory assist device (RAD) mode, and traditional ventilator mode. According to the OIG, this creates an opportunity for abuse, whereby suppliers could bill Medicare for the device as if it were being used as a ventilator, when use of a lower cost CPAP device or RAD is indicated. Because of concerns about possible abuse related to ventilator claims, two Durable Medical Equipment (DME) Medicare Administrative Contractors conducted prepayment reviews that resulted in the denial of more than 90 percent of claims for noninvasive pressure support ventilators, primarily for deficient clinical documentation.

     The Medical Device Innovation Consortium and Xavier Health have come up with suggested metrics to help medical device manufacturers improve the quality of their products and help the U.S. Food and Drug Administration enhance the consistency and quality of their inspection assessment. The proposed metrics address medical device quality from R&D, to product assembly or manufacturing, to their use in the hospital or other healthcare facility. While work continues on that process, MDIC also released metrics designed to help supply chain executives, clinicians, value analysis professionals and others compare the quality of similar products from multiple manufacturers.


    The U.S. Food and Drug Administration awarded the Medical Device Innovation Consortium (MDIC) $3 million in seed funding to establish the Coordinating Center for the Medical Device National Evaluation System for health Technology (NEST). The initial phase will include demonstration projects piloting methods for tracking medical device data and patient-reported outcomes through the use of real-world evidence. This use of real-world evidence to support product approvals/clearances of public health importance has the potential to shift premarket data collection to the postmarket setting and to meet postmarket data collection commitments through a modern system that leverages electronic health information generated in the clinical and home setting. 

    Subscribe me to the IMDA eNews Weekly Newsletter